Widely recognized as a celebrated tumor suppressor, PP2A is frequently altered or inactivated in various malignancies, leading to aberrant hyperphosphorylation of oncogenic signaling molecules, such as constitutive RAS activity (8–10). This evidence concerns the gene PTPA and neoplasm.